SOURCE: TalkPoint

TalkPoint

September 13, 2010 10:50 ET

FDAAdvisoryCommittee.com to Webcast Hearings on New Weight Loss Drugs MERIDIA and LORQESS

Two-Day Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee Will Be Streamed Live and Archived for Six Months

NEW YORK, NY--(Marketwire - September 13, 2010) -  FDAAdvisoryCommittee.com (FDAAC.com), a provider of live video webcasts of Food and Drug Administration (FDA) Advisory Committee meetings, today announced that it will webcast the Endocrinologic and Metabolic Drugs Advisory Committee's discussions on the cardiovascular implications for Meridia® as well as the safety and efficacy of Lorqess®. The Meridia meeting is scheduled for September 15, 2010 from 8:00 a.m. ET to 5:00 p.m. ET. The Lorqess meeting will be held on September 16, 2010 from 8:00 a.m. ET to 5:00 pm. ET. 

On September 15, Abbott Laboratories' new weight loss drug Meridia comes under review as experts discuss the results of clinical trials that evaluated the potential benefits of weight loss with the drug on major cardiovascular adverse events. Meridia acts as an appetite suppressant in combination with a diet and exercise regimen.

The Committee will review the safety and efficacy of Lorqess, Arena Pharmaceuticals' new diet pill, on September 16. The drug acts as an appetite suppressant and works in conjunction with diet and exercise for obese patients as determined by body mass index (BMI).

Audience members, including biotech equity analysts, pharmaceutical employees, and journalists will be able to watch from anywhere in the world as the Committee reviews Meridia and Lorqess. FDAAC.com will webcast the meeting live and on location from the Inn and Conference Center at the University of Maryland University College.

FDAAC.com is committed to delivering the highest quality of video and experience. By utilizing h.264 encoding in conjunction with Flash Media, FDAAC.com's webcasts deliver a near instantaneous stream. These high-quality streams can be accessed from anywhere around the globe and are archived for six months after the live event for unlimited review.

FDAAC.com's webcasts are powered by TalkPoint, a provider of Web-based audio and video Webcasting solutions and services. With over a decade of experience, TalkPoint has developed the most robust, scalable, interactive webcasting platform in the industry. TalkPoint's easy-to-use applications incorporate audio, video, slides, and other interactive elements to deliver high-impact webcasts cost-effectively.

To join the webcasts on September 15 and 16 at 8 a.m. ET register at http://fdaac.com

About FDAAdvisoryCommittee.com
FDAAC.com provides live video webcasts of FDA Advisory Committee meetings captured on location. These meetings cover an array of topics related to medicinal health including OTC, prescription and treatment devices. Very often meetings will result in rulings on clinical trials, final approval and bans of medications and treatment options. TalkPoint is the exclusive webcast provider for FDAAdvisoryCommitte.com.

For more information on FDAAC.com, go to www.fdaac.com.

Contact Information

  • Media Contacts:
    Richard Taber
    FDAAdvisoryCommittee.com
    Tel: (800) 627-8171
    Email Contact

    Susan Kiddy
    LVA Communications
    Tel: (860) 739-5598
    Email: Email Contact